FilingSEC EDGAR6-K
Nasus Pharma Announces CFO Resignation and Appointment of Interim CFO
· SEC accepted
StageIn Progress
Filing content
CFO Eyal Rubin will resign effective September 18, 2026, and Director of Finance Oren Elmaliach has been appointed as Interim CFO.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…